NCT07654205 Smartphone-based Intervention for Young Adults With ADHD
| NCT ID | NCT07654205 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Traci Kennedy |
| Condition | Attention Deficit/Hyperactivity Disorder(ADHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-07 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-07 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary aim is to test preliminary intervention efficacy. The main questions it aims to answer are: Is the smartphone intervention feasible \& acceptable for participants (e.g., are they responding regularly, is there a low level of burden reported)? Does the smartphone intervention improve symptom awareness, inhibitory control, and problematic alcohol use? Participants will: Attend a virtual baseline visit to assess ADHD, alcohol use, and other life experiences. Complete either the TIPS smartphone intervention or a control smartphone protocol over the course of 31-days, starting the first Friday after the baseline visit. Attend a virtual follow-up visit, where many of the same questions from the baseline visit will be asked again.
Eligibility Criteria
Inclusion Criteria: * Age 18-25 * Current diagnosis of Attention Deficit/Hyperactivity Disorder-Combined Type according to the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM 5) * Drinks at least 4 (for females) / 5 (for males) alcoholic drinks in a single drinking session at least once per week * Owns a smartphone * Reads and understands English Exclusion Criteria: * Currently in high school * Actively in treatment for Alcohol Use Disorder * Alcohol use disorder-severe
Contact & Investigator
Traci Kennedy, PhD.
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT07654205 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Attention Deficit/Hyperactivity Disorder(ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07654205 currently recruiting?
Yes, NCT07654205 is actively recruiting participants. Contact the research team at kennedytm2@upmc.edu for enrollment information.
Where is the NCT07654205 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07654205 clinical trial?
NCT07654205 is sponsored by Traci Kennedy. The principal investigator is Traci Kennedy, PhD. at University of Pittsburgh. The trial plans to enroll 70 participants.